DK0907724T3 - Von Willebrand-faktor-multimerase - Google Patents

Von Willebrand-faktor-multimerase

Info

Publication number
DK0907724T3
DK0907724T3 DK97921765T DK97921765T DK0907724T3 DK 0907724 T3 DK0907724 T3 DK 0907724T3 DK 97921765 T DK97921765 T DK 97921765T DK 97921765 T DK97921765 T DK 97921765T DK 0907724 T3 DK0907724 T3 DK 0907724T3
Authority
DK
Denmark
Prior art keywords
multimerase
von willebrand
willebrand factor
leu
vwf
Prior art date
Application number
DK97921765T
Other languages
Danish (da)
English (en)
Inventor
Bernhard Laemmle
Miha Furlan
Hans-Peter Schwarz
Peter Turecek
Johann Eibl
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT76996A external-priority patent/AT404359B/de
Priority claimed from AT77096A external-priority patent/AT404554B/de
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0907724T3 publication Critical patent/DK0907724T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Paper (AREA)
DK97921765T 1996-04-29 1997-04-25 Von Willebrand-faktor-multimerase DK0907724T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT76996A AT404359B (de) 1996-04-29 1996-04-29 Gereinigte multimerase
AT77096A AT404554B (de) 1996-04-29 1996-04-29 Pharmazeutische präparation
PCT/EP1997/002131 WO1997041206A2 (fr) 1996-04-29 1997-04-25 Multimerase purifiee

Publications (1)

Publication Number Publication Date
DK0907724T3 true DK0907724T3 (da) 2007-06-04

Family

ID=25593864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97921765T DK0907724T3 (da) 1996-04-29 1997-04-25 Von Willebrand-faktor-multimerase

Country Status (10)

Country Link
US (1) US6068838A (fr)
EP (1) EP0907724B1 (fr)
JP (2) JP2000508918A (fr)
AT (1) ATE357510T1 (fr)
CA (1) CA2253246C (fr)
DE (1) DE69737500T2 (fr)
DK (1) DK0907724T3 (fr)
ES (1) ES2285734T3 (fr)
PT (1) PT907724E (fr)
WO (1) WO1997041206A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335864A (en) 1996-11-06 2001-09-28 Univ California Isolated tumor necrosis factor receptor releasing enzyme (TRRE), compositions comprising the enzyme and methods of the use in modulation of TNF levels
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407750B (de) * 1999-02-19 2001-05-25 Immuno Ag Verfahren zur herstellung einer vwf-präparation
WO2000050904A1 (fr) * 1999-02-25 2000-08-31 Baxter Aktiengesellschaft Kit de test pour l'analyse de la protéase clivant le facteur viii
DE19957065B4 (de) 1999-11-26 2005-01-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Screening-Verfahren für Arzneistoffe
US20050153383A1 (en) * 2000-07-28 2005-07-14 Montgomery Robert R. Synthetic and recombinant substrates for the detecion of the von willebrand factor-cleaving protease
US6926894B2 (en) * 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
JP2003284570A (ja) 2001-04-25 2003-10-07 Chemo Sero Therapeut Res Inst フォンビルブラント因子（ｖＷＦ）切断酵素
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
JP2008512097A (ja) * 2004-09-07 2008-04-24 アーケミックス コーポレイション アプタマー医薬品化学
WO2008150495A2 (fr) * 2007-06-01 2008-12-11 Archemix Corp. Formulations d'aptamère vwf et procédés d'utilisation
EP2710377B8 (fr) 2011-05-19 2015-10-28 Baxalta Incorporated Détection de circulation de complexes adamts13-anticorps
WO2020214033A1 (fr) * 2019-04-17 2020-10-22 Erasmus University Medical Center Rotterdam Médicaments à base de cystéine peptidase de type papaïne et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
NL8500961A (nl) * 1985-04-01 1986-11-03 Stichting Vrienden Van De Stic Cdna-codering voor de humane von willebrand-factor, plasmiden met een dergelijke cdna-codering respektievelijk fragmenten ervan, alsmede micro-organismen, welke dergelijke plasmiden bevatten.
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
DE4434538C2 (de) * 1993-10-06 2000-08-10 Immuno Ag Verfahren zur Virusinaktivierung in Gegenwart eines Polyethers und eines chaotropen Agens
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor

Also Published As

Publication number Publication date
DE69737500D1 (de) 2007-05-03
ES2285734T3 (es) 2007-11-16
CA2253246C (fr) 2010-11-02
EP0907724A2 (fr) 1999-04-14
ATE357510T1 (de) 2007-04-15
PT907724E (pt) 2007-04-30
WO1997041206A2 (fr) 1997-11-06
WO1997041206A3 (fr) 1997-12-04
CA2253246A1 (fr) 1997-11-06
DE69737500T2 (de) 2007-11-29
US6068838A (en) 2000-05-30
JP2008289498A (ja) 2008-12-04
JP2000508918A (ja) 2000-07-18
EP0907724B1 (fr) 2007-03-21

Similar Documents

Publication Publication Date Title
ATE357510T1 (de) Von willebrand-faktor multimerase
DE68912359D1 (de) Proteolytische Enzyme und ihre Verwendung in Waschmitteln.
DE69316223D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfonamide verwendbar als retrovirale protease-inhibitoren
DE69129235D1 (de) Retrovirale proteaseinhibitoren
ATE196759T1 (de) Inhibitoren retroviraler proteasen
MX9804262A (es) Inhibidores derivados de d-aminoacidos de proteasas de cisteina y serina.
EP0677048A1 (fr) Inhibiteurs de proteases retrovirales contenant de la sulfone cyclique.
ATE335485T1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
ATE253920T1 (de) Phosphor enthaltende hemmer von cystein- und serin-proteasen
EP0975353A4 (fr) Acide peptidyl-2-amino-1-hydroxyalcanesulfonique utilise comme inhibiteur de la cysteine protease
ATE277943T1 (de) Trypsininhibitoren
AU6794994A (en) New alkaline serine protease of paecilomyces lilacinus
CA2342985A1 (fr) Inhibiteurs de la cysteine protease et de la serine protease contenant de l'hydroxamate
FI956178L (fi) Varsibromelaiiniproteaasin lääkekäyttö
ATE197716T1 (de) Waschmittelenzyme
TR28704A (tr) Düsürülmüs yüzermeli serin proteazi ve arttirilan hidroliz.
DK0717778T3 (da) Höjalkalisk serinprotease
AU2056397A (en) Hydroxyazepanes as inhibitors of glycosidase and hiv protease